An official website of the United States government Here’s how you know

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

In this section: Drugs

DDT COA #000057: Sickle Cell Pain Diary

Clinical Outcome Assessments (COA) Qualification Submissions
Office of Hematology and Oncology Products (OHOP)

DDT COA Number
DDT COA #000057

Instrument Name
Sickle Cell Pain Diary

Disease/Condition
Sickle Cell Disease (SCD)
Concept of Interest
Pain intensity and pain interference

Context of Use
Pediatric patients with SCD

COA Type
PRO

Qualification Stage
In transition to 507 process

Requestor(s)
Lakshmanan Krishnamurti

Contact(s)
Lakshmanan Krishnamurti

Date Accepted into CDER’s COA Qualification Program
February 14, 2014

Back to Clinical Outcome Assessments (COA) Qualification Submission

Content current as of:

12/07/2018
Regulated Product(s)
- Drugs
- Drug Development Tools

DDT COA #000057: Sickle Cell Pain Diary

Clinical Outcome Assessments (COA) Qualification Submissions Office of Hematology and Oncology Products (OHOP)

Clinical Outcome Assessments (COA) Qualification Submissions
Office of Hematology and Oncology Products (OHOP)